SVA Share Price

Open 5.96 Change Price %
High 5.96 1 Day -0.08 -1.35
Low 5.79 1 Week -0.15 -2.50
Close 5.86 1 Month 0.31 5.59
Volume 36098 1 Year 1.00 20.58
52 Week High 7.16
52 Week Low 4.38
SVA Important Levels
Resistance 2 6.02
Resistance 1 5.95
Pivot 5.87
Support 1 5.77
Support 2 5.70
NASDAQ USA Most Active Stocks
ASTI 0.00 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
DRYS 1.01 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ACAS 17.99 0.39%
More..
NASDAQ USA Top Gainers Stocks
CPSL 0.10 66.67%
LOCM 0.09 50.00%
GLBS 9.70 31.79%
LTRE 2.85 29.55%
ETRM 7.96 29.22%
INFI 2.00 29.03%
QKLS 0.14 27.27%
PRKR 2.57 26.60%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
More..
NASDAQ USA Top Losers Stocks
HEAT 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
AMCF 0.03 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
More..

Sinovac Biotech, Ltd. (NASDAQ: SVA)

SVA Technical Analysis 3
As on 20th Jan 2017 SVA Share Price closed @ 5.86 and we RECOMMEND Sell for LONG-TERM with Stoploss of 6.06 & Sell for SHORT-TERM with Stoploss of 6.02 we also expect STOCK to react on Following IMPORTANT LEVELS.
SVA Target for January
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
SVA Other Details
Segment EQ
Market Capital 148553632.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.sinovac.com
SVA Address
SVA
No. 39 Shangdi Xi Road
Haidian District
Beijing, 100085
China
Phone: 86 10 8289 0088
Fax: 86 10 6296 6910
SVA Latest News
Stock Checkup: Technical Watch on Sinovac Biotech Ltd. (SVA)   Yankee Analysts   - 20th Jan 17
Sinovac Biotech Ltd. and Vanda Pharmaceuticals, Inc. Head to Head Compare   CML News   - 20th Jan 17
Stock Returns: FibroGen Inc (NASDAQ:FGEN) versus Sinovac Biotech Ltd. (NASDAQ:SVA)   CML News   - 19th Jan 17
INVESTOR ALERT: Lundin Law PC Announces an Investigation of Sinovac Biotech ...   Yahoo Finance   - 11th Jan 17
Sinovac Responds to Recent Report   PR Newswire (press release)   - 23rd Dec 16
Sinovac Announces Results of 2016 Annual General Meeting of Shareholders   PR Newswire (press release)   - 31st Oct 16
Heng Ren Rejects Sinovac Insider Buyout Offer   Benzinga   - 31st Aug 16
Sinovac Special Committee Engages Financial and Legal Advisors   PR Newswire (press release)   - 14th Apr 16
Sinovac Provides Updates on Pipeline Vaccines   PR Newswire (press release)   - 17th Mar 15
News Sinovac Biotech Ltd.SVA   Wall Street Journal   - 11th Feb 11
Interactive Technical Analysis Chart Sinovac Biotech, Ltd. ( SVA NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Sinovac Biotech, Ltd.
SVA Business Profile
Sinovac Biotech Ltd. (Sinovac) is a holding company. The Company is an integrated China-based biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases, including hepatitis A, hepatitis A and B, seasonal influenza, H5N1 and H1N1 pandemic influenza and mumps, as well as animal rabies vaccine. The Company�s product pipeline also includes human vaccines against rotavirus, and human rabies that are in pre-clinical development. The Company specializes in the sales, marketing, manufacturing, and development of vaccines for infectious disease with unmet medical need. The Company�s pipeline consists of vaccine candidates in the clinical and pre-clinical development phases in China, including the EV71 vaccine and human vaccines for pneumococcal, rotavirus, rabies, varicella and rubella.